Edition:
United Kingdom

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

48.20USD
12 Dec 2017
Change (% chg)

$0.01 (+0.02%)
Prev Close
$48.19
Open
$47.60
Day's High
$48.69
Day's Low
$47.49
Volume
51,082
Avg. Vol
76,011
52-wk High
$51.33
52-wk Low
$25.92

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Bruce Carter

73 2015 Chairman of the Board,Independent Director

Jay Luly

60 2003 President, Chief Executive Officer, Director

Paul Mellett

61 2003 Chief Financial Officer, Senior Vice President - Finance & Administration

Yat Sun Or

64 1999 Senior Vice President - Research & Development, Chief Scientific Officer

Nathaniel Gardiner

63 2014 Senior Vice President, General Counsel